The global bilirubin blood test market is set for significant growth, with market size expected to reach USD 2.30 billion by 2030. This represents a robust compound annual growth rate (CAGR) of 6.32% during the forecast period from 2023 to 2030. The market's expansion is driven by advancements in diagnostic technologies, increasing prevalence of liver diseases, and the residual...

The global HLA typing market, valued at USD 1.5 billion in 2022, is projected to reach USD 2.50 billion by 2030. This represents a robust compound annual growth rate (CAGR) of 6.6% over the forecast period from 2023 to 2030. The market's expansion is driven by technological advancements, increasing demand for organ transplants, and the lingering impacts of the COVID-19 pandemic. Key...